Remember Me
Or use your Academic/Social account:


Or use your Academic/Social account:


You have just completed your registration at OpenAire.

Before you can login to the site, you will need to activate your account. An e-mail will be sent to you with the proper instructions.


Please note that this site is currently undergoing Beta testing.
Any new content you create is not guaranteed to be present to the final version of the site upon release.

Thank you for your patience,
OpenAire Dev Team.

Close This Message


Verify Password:
Verify E-mail:
*All Fields Are Required.
Please Verify You Are Human:
fbtwitterlinkedinvimeoflicker grey 14rssslideshare1
Goodfellow, Nicola A.; Hawwa, Ahmed F.; Reid, Alastair J.M.; Horne, Rob; Shields, Michael D.; McElnay, James C.
Publisher: Springer Nature
Journal: BMC Pulmonary Medicine
Languages: English
Types: Article
Subjects: Research Article, Pulmonary and Respiratory Medicine, Cystic fibrosis, Adolescent, Medication adherence, Beliefs, Parents, Child
Background Adherence to treatment is often reported to be low in children with cystic fibrosis. Adherence in cystic fibrosis is an important research area and more research is needed to better understand family barriers to adherence in order for clinicians to provide appropriate intervention. The aim of this study was to evaluate adherence to enzyme supplements, vitamins and chest physiotherapy in children with cystic fibrosis and to determine if any modifiable risk factors are associated with adherence. Methods A sample of 100 children (≤18 years) with cystic fibrosis (44 male; median [range] 10.1 [0.2-18.6] years) and their parents were recruited to the study from the Northern Ireland Paediatric Cystic Fibrosis Centre. Adherence to enzyme supplements, vitamins and chest physiotherapy was assessed using a multi-method approach including; Medication Adherence Report Scale, pharmacy prescription refill data and general practitioner prescription issue data. Beliefs about treatments were assessed using refined versions of the Beliefs about Medicines Questionnaire-specific. Parental depressive symptoms were assessed using the Center for Epidemiologic Studies Depression Scale. Results Using the multi-method approach 72% of children were classified as low-adherers to enzyme supplements, 59% low-adherers to vitamins and 49% low-adherers to chest physiotherapy. Variations in adherence were observed between measurement methods, treatments and respondents. Parental necessity beliefs and child age were significant independent predictors of child adherence to enzyme supplements and chest physiotherapy, but parental depressive symptoms were not found to be predictive of adherence. Conclusions Child age and parental beliefs about treatments should be taken into account by clinicians when addressing adherence at routine clinic appointments. Low adherence is more likely to occur in older children, whereas, better adherence to cystic fibrosis therapies is more likely in children whose parents strongly believe the treatments are necessary. The necessity of treatments should be reinforced regularly to both parents and children. Electronic supplementary material The online version of this article (doi:10.1186/s12890-015-0038-7) contains supplementary material, which is available to authorized users.
  • The results below are discovered through our pilot algorithms. Let us know how we are doing!

    • 1. Sabaté E. Adherence to long-term therapies: evidence for action. Geneva: World Health Organisation; 2003.
    • 2. Sawicki GS, Ren CL, Konstan MW, Millar SJ, Pasta DJ, Quittner AL. Treatment complexity in cystic fibrosis: trends over time and associations with site-specific outcomes. J Cyst Fibros. 2013;12:461-7.
    • 3. Modi AC, Quittner AL. Barriers to treatment adherence for children with cystic fibrosis and asthma: what gets in the way? J Pediatr Psychol. 2006;31:846-58.
    • 4. Eakin MN, Bilderback A, Boyle MP, Mogayzel PJ, Riekert KA. Longitudinal association between medication and lung health in people with cystic fibrosis. J Cyst Fibros. 2011;10:258-64.
    • 5. Briesacher BA, Quittner AL, Saiman L, Sacco P, Fouayzi H, Quittell LM. Adherence with tobramycin inhaled solution and health care utilisation. BMC Pulm Med. 2011;11:5.
    • 6. Horne R, Weinman J. Patients' beliefs about prescribed medicines and their role in adherence to treatment in chronic physical illness. J Psychosom Res. 1999;47:555-67.
    • 7. Phatak HM, Thomas 3rd J. Relationships between beliefs about medications and non-adherence to prescribed chronic medications. Ann Pharmacother. 2006;40:1737-42.
    • 8. Horne R. Assessing perceptions of medication: psychological perspectives. In: McGavock H, editor. Handbook of drug use research methodology. 1st ed. UK: Drug Utilization Research Group; 2000. p. 1-20.
    • 9. Horne R, Buick D, Fisher M, Leake H, Cooper V, Weinman J. Doubts about necessity and concerns about adverse effects: identifying the types of beliefs that are associated with non-adherence to HAART. Int J STD AIDS. 2004;15:38-44.
    • 10. Bucks RS, Hawkins K, Skinner TC, Horn S, Seddon P, Horne R. Adherence to treatment in adolescents with cystic fibrosis: the role of illness perceptions and treatment beliefs. J Pediatr Psychol. 2009;34:893-902.
    • 11. Sawicki GS, Heller KS, Demars N, Robinson WM. Motivating adherence among adolescents with cystic fibrosis: Youth and parent perspectives. Pediatr Pulmonol. 2015;50:127-36.
    • 12. Conn KM, Halterman JS, Lynch K, Cabana MD. The impact of parent's medication beliefs on asthma management. Pediatrics. 2007;120:e521-6.
    • 13. Bartlett SJ, Krishnan JA, Riekert KA, Butz AM, Malveaux FJ, Rand CS. Maternal depressive symptoms and adherence to therapy in inner-city children with asthma. Pediatrics. 2004;113:229-37.
    • 14. Quittner AL, Goldbeck L, Abbott J, Duff A, Lambrecht P, Solé A, et al. Prevalence of depression and anxiety in patients with cystic fibrosis and parent caregivers: results of The International Depression Epidemiological Study across nine countries. Thorax. 2014;69:1090-7.
    • 15. Quittner AL, Barker DH, Geller D, Butt S, Gondor M. Effects of maternal depression on electronically monitored enzyme adherence and changes in weight for children with CF. J Cyst Fibros. 2007;6 Suppl 1:S78.
    • 16. Smith BA, Wood BL. Psychological factors affecting disease activity in children and adolescents with cystic fibrosis: medical adherence as a mediator. Curr Opin Pediatr. 2007;19:553-8.
    • 17. Smith BA, Modi AC, Quittner AL, Wood BL. Depressive symptoms in children with cystic fibrosis and parents and its effects on adherence to airway clearance. Pediatr Pulmonol. 2010;45:756-63.
    • 18. Sheehan J, Massie J, Hay M, Jaffe A, Glazner J, Armstrong D, et al. The natural history and predictors of persistent problem behaviours in cystic fibrosis: a multi-centre, prospective study. Arch Dis Child. 2012;97:625-31.
    • 19. Horne R, Weinman J. Self-regulation and self-management in asthma: exploring the role of illness perceptions and treatment beliefs in explaining non-adherence to preventer medication. Psychol Health. 2002;17:17-32.
    • 20. McCullough AR, Tunney MM, Quittner AL, Elborn JS, Bradley JM, Hughes CM. Treatment adherence and health outcomes in patients with bronchiectasis. BMC Pulm Med. 2014;14:107.
    • 21. Haynes RB, Taylor DW, Sackett DL, Gibson ES, Bernholz CD, Mukherjee J. Can simple clinical measurements detect patient non-compliance? Hypertension. 1980;2:757-64.
    • 22. Hess LM, Raebel MA, Conner DA, Malone DC. Measurement of adherence in pharmacy administrative databases: a proposal for standard definitions and preferred measures. Ann Pharmacother. 2006;40:1280-8.
    • 23. Radloff LS. The CES-D scale: a self-report depression scale for research in the general population. Appl Psychol Meas. 1977;1:385-401.
    • 24. Driscoll KA, Montag-Leifling K, Acton JD, Modi AC. Relations between depressive and anxious symptoms and quality of life in caregivers of children with cystic fibrosis. Pediatr Pulmonol. 2009;44:784-92.
    • 25. Geisser ME, Randy R, Robinson ME. Assessing depression among persons with chronic pain using the Centre for Epidemiological Studies-Depression Scale and the Beck Depression Inventory: a comparative analysis. Clin J Pain. 1997;13:163-70.
    • 26. White T, Miller J, Smith GL, McMahon WM. Adherence and psychopathology in children and adolescents with cystic fibrosis. Eur Child Adolesc Psychiatry. 2009;18:96-104.
    • 27. Llorente RPA, Garcia CB, Martin JJD. Treatment compliance in children and adults with cystic fibrosis. J Cyst Fibros. 2008;7:359-67.
    • 28. Daniels T, Goodacre L, Sutton C, Pollard K, Conway S, Peckham D. Accurate assessment of adherence: self-report and clinician report vs electronic monitoring of nebulizers. Chest. 2011;140:425-32.
    • 29. Simon SL, Duncan CL, Horky SC, Nick TG, Castro MM, Riekert KA. Body satisfaction, nutritional adherence and quality of life in youth with cystic fibrosis. Pediatr Pulmonol. 2011;46:1085-92.
    • 30. Duff AJ, Abbott J, Cowperthwaite C, Sumner C. Anxiety and depression in CF in the UK (TIDES-UK). J Cyst Fibros. 2012;11 Suppl 1:S138.
  • No related research data.
  • Discovered through pilot similarity algorithms. Send us your feedback.